Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,098
Closed -$222K 129
2020
Q4
$222K Buy
1,098
+4
+0.4% +$828 0.07% 114
2020
Q3
$230K Buy
1,094
+3
+0.3% +$668 0.09% 109
2020
Q2
$239K Buy
+1,091
New +$218K 0.09% 106
2019
Q2
Sell
-1,274
Closed -$204K 137
2019
Q1
$204K Sell
1,274
-390
-23% -$60.5K 0.08% 128
2018
Q4
$256K Sell
1,664
-215
-11% -$33.5K 0.15% 98
2018
Q3
$283K Sell
1,879
-151
-7% -$21.5K 0.16% 93
2018
Q2
$274K Buy
2,030
+9
+0.4% +$1.11K 0.12% 109
2018
Q1
$261K Buy
+2,021
New +$271K 0.12% 117
2017
Q3
Sell
-1,938
Closed -$259K 74
2017
Q2
$259K Buy
1,938
+69
+4% +$9.31K 0.13% 118
2017
Q1
$252K Buy
1,869
+5
+0.3% +$648 0.13% 117
2016
Q4
$221K Buy
+1,864
New +$220K 0.12% 127

Other funds holding CLX

Bridgeworth's CLX Position: Q1 2021 in Review

Bridgeworth sold out of Clorox (CLX) in Q1 2021, closing a stake of 1,098 shares — an estimated $222K sold.

Bridgeworth first reported a position in CLX in Q4 2016 and held it in 11 quarters. The position peaked at $283K in Q3 2018. 1,207 funds tracked by Wall St. Rank hold CLX as of Q1 2021.

  • Bridgeworth reported no remaining Clorox position as of Q1 2021 after selling out during the quarter.
  • Bridgeworth sold 1,098 Clorox shares in Q1 2021, an estimated $222K.
  • Bridgeworth first reported a position in Clorox in Q4 2016 and held it in 11 quarters.
  • Bridgeworth's Clorox position peaked at $283K in Q3 2018.
  • 1,207 funds tracked by Wall St. Rank held Clorox as of Q1 2021.

Based on Bridgeworth's 13F filing for Q1 2021, filed 14 May 2021.